Helus Pharma Inc.
For the period ended Mar 31, 2024. Filed Jun 26, 2024.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Jun 26, 2024
Use the contents to explore the available documents and sections.
Contents
CODE OF ETHICS
The Company has adopted a code of ethics (the “Code of Business Conduct”) that applies to all employees and officers, and directors. The Code of Business Conduct is available on the Company's corporate website at https://ir.cybin.com/investors/governance/governance-documents. [Any amendments to the Code of Business Conduct will be posted at the Company’s Internet website at the address listed above.][Note to Draft: Cybin to advise whether any amendments were made to the Code or whether Cybin granted a waiver from a provision of the Code to the company’s CEO, CFO, Chief Financial Officer or any other person performing a similar role during the 2024 fiscal year.]
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.